Novartis announced today that the FDA has granted Breakthrough Therapy designation to ianalumab for Sjogren’s disease, strengthening its path toward becoming the first targeted treatment for this autoimmune condition.
Sun Pharmaceutical Industries has launched Unloxcyt in the United States following FDA approval of an updated label, expanding treatment options for patients with advanced cutaneous squamous cell carcinoma.
Boston Scientific Corporation has signed a definitive agreement to acquire US-based medical device company Penumbra Inc. in a transaction valued at approximately $14.5 billion, strengthening its presence in vascular and neurovascular therapi...
Max Healthcare has collaborated with Google to allow patients to book hospital appointments directly from Google Search and Maps, making access to verified care faster, simpler, and more reliable across India.
Entod Pharmaceuticals has developed the world's first losartan eye drops to treat corneal scarring, a major cause of vision loss. The innovation marks a global milestone in ophthalmic drug formulation.
Abbott has entered into a strategic collaboration with AtaCor Medical to develop an investigational extravascular implantable cardioverter defibrillator (EV-ICD) system, aimed at improving the safety and effectiveness of therapy for patien...
Illumina, Inc. has announced the launch of the Illumina Billion Cell Atlas, a large-scale genomic dataset intended to strengthen the scientific foundation of drug discovery and biomedical research. The announcement was made from San Diego on Thurs...
Boehringer Ingelheim has initiated a phase IIa clinical trial to evaluate BI 765423, a monoclonal antibody targeting interleukin-11 (IL-11), for the treatment of idiopathic pulmonary fibrosis (IPF). The study is part of the company’s ongoing resea...
Zydus Lifesciences has received USFDA approval for its generic Eltrombopag tablets, strengthening its U.S. generics portfolio and opening access to a blood disorder drug with strong commercial potential.
As health-tech startups and pharmaceutical innovators drive rapid adoption of injectable weight-loss drugs, new UK research has raised questions about their durability as long-term obesity solutions. While medications such as semaglutide (Wegovy...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")